I

1 1000-s

- DlaJon -Glucophage®

0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 Time (Hours)

0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 Time (Hours)

Final Report Issuance Date

19 April 2007

/^THIS STUDY WAS CONDUCTED IN ACCORDANCE WITH INTERNATIONAL CONFERENCE OF^ HARMONIZATION (ICH) GOOD CLINICAL PRACTICE (GCP) GUIDELINES ADOPTED BY THE EUROPEAN AGENCY FOR THE EVALUATION OF MEDICINAL PRODUCTS (EMEA).

ESSENTIAL DOCUMENTS AND RECORDS WERE ALL ARCHIVED ACCORDING TO INTERNATIONAL PHARMACEUTICAL RESEARCH CENTER (IPRC) INTERNAL PROCEDURES FOR AUTHORIZED DIRECT ACCESS

THIS FINAL REPORT WAS GENERATED IN REFERENCE TO INTERNATIONAL CONFERENCE OF HARMONIZATION (ICH) GUIDELINES ADOPTED BY THE EUROPEAN AGENCY FOR THE EVALUATION OF MEDICINAL PRODUCTS (EMEA) FOR STRUCTURE AND CONTENT OF CLINICAL STUDY REPORTS

Was this article helpful?

0 0

Post a comment